文献速递临床试验与 GCP流行病学与生物统计

院外心脏骤停复苏后患者较低与较高血氧饱和度目标对出院生存率的影响:EXACT随机临床试验

Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01

这项多中心随机临床试验在澳大利亚维多利亚州和南澳大利亚州纳入428例院外心脏骤停复苏后患者,随机接受血氧饱和度90%至94%或98%至100%的氧疗目标。干预组出院生存率为38.3%,标准组为47.9%,差异未达统计学显著;干预组院前缺氧发作比例更高。

要点

  • 院外心脏骤停复苏后至ICU前,血氧目标90%至94%较98%至100%未显著改善出院生存率。
  • 干预组出院生存38.3% vs 标准组47.9%,差异-9.6%(95%CI -18.9%至-0.2%),未校正OR 0.68(95%CI 0.46-1.00,P=.05)。
  • 干预组ICU前缺氧发作31.3% vs 标准组16.1%,OR 2.37(95%CI 1.49-3.79,P<.001)。

核心结论

  • 院外心脏骤停复苏后至ICU前,血氧目标90%至94%较98%至100%未显著改善出院生存率。
  • 尽管试验因COVID-19疫情提前终止,结果不支持在院外心脏骤停复苏后使用90%至94%的血氧饱和度目标。

研究设计与样本

  • 多中心、平行组随机临床试验,在澳大利亚维多利亚州和南澳大利亚州的2个急救医疗服务机构和15家医院开展。
  • 纳入院外心脏骤停复苏后意识不清、接受100%氧气时外周血氧饱和度至少95%的成人,计划纳入1416例,实际纳入428例。
  • 患者由急救人员随机分为血氧饱和度90%至94%组(干预组,n=216)或98%至100%组(标准组,n=212),直至到达重症监护室。
  • 试验于2017年12月11日至2020年8月11日进行,数据收集自救护车和医院病历,最终随访日期为2021年8月25日。
  • 主要分析纳入425例(中位年龄65.5岁;女性100例[23.5%]),全部完成试验。

主要发现

  • 干预组214例中82例(38.3%)存活至出院,标准组211例中101例(47.9%)存活至出院,差异-9.6%(95%CI -18.9%至-0.2%),未校正OR 0.68(95%CI 0.46-1.00,P=.05)。
  • 9项预设次要结局中8项无显著差异。
  • ICU前缺氧发作在干预组为31.3%(n=67),标准组为16.1%(n=34),差异15.2%(95%CI 7.2%-23.1%),OR 2.37(95%CI 1.49-3.79,P<.001)。

临床怎么用

  • 作者认为,结果不支持在院外心脏骤停复苏后使用90%至94%的血氧饱和度目标。

局限性

  • 试验因COVID-19疫情提前终止。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The administration of a high fraction of oxygen following return of spontaneous circulation in out-of-hospital cardiac arrest may increase reperfusion brain injury. OBJECTIVE: To determine whether targeting a lower oxygen saturation in the early phase of postresuscitation care for out-of-hospital cardiac arrest improves survival at hospital discharge. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, parallel-group, randomized clinical trial included unconscious adults with return of spontaneous circulation and a peripheral oxygen saturation (Spo2) of at least 95% while receiving 100% oxygen. The trial was conducted in 2 emergency medical services and 15 hospitals in Victoria and South Australia, Australia, between December 11, 2017, and August 11, 2020, with data collection from ambulance and hospital medical records (final follow-up date, August 25, 2021). The trial enrolled 428 of a planned 1416 patients. INTERVENTIONS: Patients were randomized by paramedics to receive oxygen titration to achieve an oxygen saturation of either 90% to 94% (intervention; n = 216) or 98% to 100% (standard care; n = 212) until arrival in the intensive care unit. MAIN OUTCOMES AND MEASURES: The primary outcome was survival to hospital discharge. There were 9 secondary outcomes collected, including hypoxic episodes (Spo2 <90%) and prespecified serious adverse events, which included hypoxia with rearrest. RESULTS: The trial was stopped early due to the COVID-19 pandemic. Of the 428 patients who were randomized, 425 were included in the primary analysis (median age, 65.5 years; 100 [23.5%] women) and all completed the trial. Overall, 82 of 214 patients (38.3%) in the intervention group survived to hospital discharge compared with 101 of 211 (47.9%) in the standard care group (difference, -9.6% [95% CI, -18.9% to -0.2%]; unadjusted odds ratio, 0.68 [95% CI, 0.46-1.00]; P = .05). Of the 9 prespecified secondary outcomes collected during hospital stay, 8 showed no significant difference. A hypoxic episode prior to intensive care was observed in 31.3% (n = 67) of participants in the intervention group and 16.1% (n = 34) in the standard care group (difference, 15.2% [95% CI, 7.2%-23.1%]; OR, 2.37 [95% CI, 1.49-3.79]; P < .001). CONCLUSIONS AND RELEVANCE: Among patients achieving return of spontaneous circulation after out-of-hospital cardiac arrest, targeting an oxygen saturation of 90% to 94%, compared with 98% to 100%, until admission to the intensive care unit did not significantly improve survival to hospital discharge. Although the trial is limited by early termination due to the COVID-19 pandemic, the findings do not support use of an oxygen saturation target of 90% to 94% in the out-of-hospital setting after resuscitation from cardiac arrest. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03138005.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Bernard SA, Bray JE, Smith K, et al. Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial. JAMA. 2022. PMID: 36286192. doi:10.1001/jama.2022.17701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。